Drusen subregion staining may not be linked to macula drusen in AMD

Article

Drusen subregion staining may not be directly linked to in vivo observations of macula drusen in age-related macula degeneration (AMD).

Drusen subregion staining may not be directly linked to in vivo observations of macula drusen in age-related macula degeneration (AMD), states a paper in the journal Retina.

Dr Duncan Friedman et al., Department of Ophthalmology, School of medicine, University of Alabama, Birmingham, Alabama, USA, evaluated macula drusen from 35 patients with AMD. This was completed by measuring drusen area with colour digital images and fluorescein angiograms.

In total, 828 drusen were assessed and 405 of these presented with a corresponding fluorescein angiogram signal. Drusen was stained in 49.57% of patients and drusen measured in fluorescein images did not significantly differ from drusen sizes measured by colour digital images.

The study discovered that the current understanding of drusen subregion staining is not directly linked to in vivo observations found in AMD macula drusen.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.